AVO is focused on delivering a more affordable, novel, proton-based radiotherapy system, based on technology originally developed at the world renowned CERN. The company is entering an exciting stage with construction of its Harley Street site well underway and on schedule, with the site expected to be ready for installation by end 1H’19.
While the interim results provide a commercial and financial update, AVO continues its progress in accelerating the proton beam and is on-track in building a machine capable of treating superficial tumours by 3Q’18. The financing has been on a rocky road but confidence is building up as the proton accelerates.
2017 interim results
Successful integration of the different modules of the LIGHT system highlight the reduced technical risk inherent to the development of the LIGHT accelerator. All the different components have been tested individually, and more units are successfully being integrated. To date, three – the proton source, the RFQ and the first SCDTL – of the four main structures have been integrated and the proton beam generated and accelerated up to an energy of 7.5MeV, which is a major achievement. The fourth element – the CCL(s) – has been received at the Geneva testing facility and are less technically challenging to integrate as they have already been validated by the LIBO prototype, which was a high-speed unit that has already been integrated (with another accelerator).
Link here to full research note